Clinical Trials Browser

Recruiting × Observational × Sentinel Lymph Node Biopsy × Clear all

NCT07508306 2026-04-02

Patent Blue SLN in Early Ovarian Cancer Prospective Study (FIGO I-II) Evaluating Patent Blue SLN Mapping. Injection Into IP/UO Ligaments in Situ. Goals: Assess Feasibility and Accuracy vs Standard Lymphadenectomy to Minimize Surgical Morbidity

Sentinel Lymph Node Biopsy (SLNB)

NCT06619002 2024-10-02

LYSE

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT05797415 2024-10-01

BLS

Carcinoma, Merkel Cell, Eccrine Porocarcinoma